|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/33 | |
| A61K 47/10 | |||
| A61K 47/32 | |||
| A61P 11/00 |
| (11) | Number of the document | 2021797 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07762162.1 |
| Date of filing the European patent application | 2007-05-14 | |
| (97) | Date of publication of the European application | 2009-02-11 |
| (45) | Date of publication and mention of the grant of the patent | 2011-11-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2007/068857 |
| Date | 2007-05-14 |
| (87) | Number | WO 2007/134279 |
| Date | 2007-11-22 |
| (30) | Number | Date | Country code |
| 799795 P | 2006-05-12 | US |
| (72) |
YOUNG, Christopher, R., US
ROWE, Charles, William, US
|
| (73) |
Vertex Pharmaceuticals, Inc.,
130 Waverly Street, Cambridge, MA 02139,
US
|
| (54) | COMPOSITIONS OF N-Ý2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL¨-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXAMIDE |
| COMPOSITIONS OF N-Ý2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL¨-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXAMIDE |